| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/05/2007 | WO2007056281A3 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007056184A3 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007038058A3 Amino-aza-adamantane derivatives and methods of use |
| 07/05/2007 | WO2006108693A3 Process for preparing bicyclic compounds |
| 07/05/2007 | WO2006071862A3 Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate |
| 07/05/2007 | WO2006069080A3 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 07/05/2007 | WO2006064517A3 Methods for the purification of 20(s)-camptothecin |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | WO2006053024A3 Lactam compounds and their use as pharmaceuticals |
| 07/05/2007 | US20070155968 by reacting a perylene-3,4-dicarboximide in the presence of a base-stable, high-boiling organic solvent and of an alkali metal or alkaline earth metal base, with a naphthalene-1,8-dicarboximide; less toxic; higher yield; shorter reaction times |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155817 Indolylmaleimide derivatives |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 07/05/2007 | US20070155779 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/05/2007 | US20070155777 Antiinflammation agents |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155767 Sulfone substituted imidazo ring ethers |
| 07/05/2007 | US20070155761 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/05/2007 | US20070155743 suchas N-(4(S)-amino-5(S)-hydroxy-2(S)-isopropyl-6-piperidin-1-ylhexyl)-2-(3-methoxypropoxy)benzamide dihydrochloride, used for the treatment of hypertension, cardiovasculr disorders, complications owing to diabetes, vision deffects, hyperaldosteronism, states of anxiety and cognitive disorders |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 07/05/2007 | US20070155722 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070154980 Fluorescent dyes |
| 07/05/2007 | US20070154937 N-sulfonyldicarboximide containing tethering compounds |
| 07/05/2007 | DE102005061997A1 New naphthalene compound useful, e.g. in semiconductors, preferably organic field effect transistor and photovoltaic units and as UV-absorber and optical brightener |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2635214A1 Compounds useful in cftr assays and methods therewith |
| 07/05/2007 | CA2634999A1 Muscarinic agonists and methods of use thereof |
| 07/05/2007 | CA2634923A1 Acetylenic bicyclic heteroaryl compounds useful as kinase inhibitors |
| 07/05/2007 | CA2634907A1 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 07/05/2007 | CA2634456A1 Modulators of muscarinic receptors |
| 07/05/2007 | CA2634250A1 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 07/05/2007 | CA2633760A1 Anti-viral compounds |
| 07/05/2007 | CA2633757A1 Anti-viral compounds |
| 07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
| 07/05/2007 | CA2633536A1 Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
| 07/04/2007 | EP1803722A1 Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/04/2007 | EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2007 | EP1802623A1 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 07/04/2007 | EP1802622A1 Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed halogen hydrocide is continuously removable from the organic solvent |
| 07/04/2007 | EP1802621A1 Crf receptor antagonists and methods relating thereto |
| 07/04/2007 | EP1802620A1 Method for enantioselective preparation of sulphoxide derivatives |
| 07/04/2007 | EP1802619A1 Inhibitors of the hiv integrase enzyme |
| 07/04/2007 | EP1802618A1 Biphenyl integrin antagonists |
| 07/04/2007 | EP1802602A1 Substituted dipiperdine ccr2 antagonists |
| 07/04/2007 | EP1802306A2 Quinolone analog as cell proliferation inhibitors |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | EP1539751A4 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 07/04/2007 | EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | CN1993446A Red electroluminescent compounds and organic electroluminescent device using the same |
| 07/04/2007 | CN1993360A Condensed pyridines as kinase inhibitors |
| 07/04/2007 | CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 07/04/2007 | CN1993325A Piperidine derivatives as histamine h3 receptor ligands |
| 07/04/2007 | CN1993127A Azaindoles modulating c-kit activity and uses therefor |
| 07/04/2007 | CN1990488A N型有机半导体材料 N-type organic semiconductor material |
| 07/04/2007 | CN1324028C Variolin derivatives as anti-cancer agents |
| 07/04/2007 | CN1324027C Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material using the derivatives |
| 07/04/2007 | CN1324013C Aryl Fused azapolycyclic compounds |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238720 Pharmaceutical use of N-carbamoylazole derivatives |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238706 For therapy of asthma and inflammation and useful for the enhancement of cognition |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 07/03/2007 | US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity |
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/03/2007 | CA2188306C Process for the diastereoselective synthesis of nucleoside analogues |
| 06/28/2007 | WO2007073405A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 06/28/2007 | WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 06/28/2007 | WO2007071965A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines |
| 06/28/2007 | WO2007071936A1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 06/28/2007 | WO2007071621A1 Heteroarylpyrrolopyridinones active as kinase inhibitors |
| 06/28/2007 | WO2007071434A1 Antiviral 2-carboxy-thiophene compounds |
| 06/28/2007 | WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | WO2007070984A1 Spiroketals |
| 06/28/2007 | WO2007053353A3 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 06/28/2007 | WO2007053352A3 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
| 06/28/2007 | WO2007050576A3 A method of preparing a 4-oxo-1- (3 substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3- carboxamide phosphodiesterase-4 inhibitor |
| 06/28/2007 | WO2006084073A3 Aqueous gel formulations containing 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| 06/28/2007 | WO2006029115A3 2-amino 1h imidazo ring systems and methods |
| 06/28/2007 | WO2004000210A3 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| 06/28/2007 | US20070149783 Process for preparing topotecan |
| 06/28/2007 | US20070149603 Ppar active compounds |
| 06/28/2007 | US20070149561 Azaindole inhibitors of aurora kinases |
| 06/28/2007 | US20070149560 Novel fused triazolones and the uses thereof |
| 06/28/2007 | US20070149557 CXCR3 antagonists |
| 06/28/2007 | US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use |
| 06/28/2007 | US20070149541 Imidazole compounds |
| 06/28/2007 | US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative |
| 06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |